Soc. Generale Knock-Out OMV/ DE000SQ2PR60 /
04/10/2024 21:46:54 | Chg.+0.030 | Bid21:47:23 | Ask21:47:23 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.540EUR | +5.88% | 0.550 Bid Size: 5,500 |
0.570 Ask Size: 5,500 |
OMV AG | 34.2748 EUR | 31/12/2078 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center